Massimo Santoro

Active 1987–2025

184
Papers
36,218
Citations
108
h-index
181
i10-index

Citations

Citations per year for Massimo Santoro1988: 1 citations1989: 1 citations1990: 13 citations1991: 20 citations1992: 22 citations1993: 25 citations1994: 51 citations1995: 49 citations1996: 82 citations1997: 77 citations1998: 112 citations1999: 103 citations2000: 210 citations2001: 183 citations2002: 231 citations2003: 281 citations2004: 257 citations2005: 351 citations2006: 491 citations2007: 380 citations2008: 382 citations2009: 366 citations2010: 344 citations2011: 392 citations2012: 309 citations2013: 340 citations2014: 279 citations2015: 228 citations2016: 245 citations2017: 287 citations2018: 225 citations2019: 854 citations2020: 965 citations2021: 841 citations2022: 674 citations2023: 501 citations2024: 714 citations2025: 328 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,985 citing papers, 25.9% of this breakdownChina: 1,458 citing papers, 12.7% of this breakdownItaly: 1,157 citing papers, 10% of this breakdownGermany: 605 citing papers, 5.3% of this breakdownUnited Kingdom: 556 citing papers, 4.8% of this breakdownJapan: 367 citing papers, 3.2% of this breakdownFrance: 343 citing papers, 3% of this breakdownCanada: 329 citing papers, 2.9% of this breakdownSpain: 264 citing papers, 2.3% of this breakdownSouth Korea: 256 citing papers, 2.2% of this breakdownAustralia: 234 citing papers, 2% of this breakdownIndia: 230 citing papers, 2% of this breakdown
0%25.9%Other 23.7%

Fields

  • Medicine51.2%
  • Biochemistry, Genetics and Molecular Biology38.4%
  • Immunology and Microbiology3.2%
  • Neuroscience2.2%
  • Engineering1.3%
  • Materials Science0.6%
  • Other3.1%

Topics

  • Thyroid Cancer Diagnosis and Treatment6.7%
  • MicroRNA in disease regulation3.7%
  • Cancer-related molecular mechanisms research2.6%
  • Cancer-related Molecular Pathways2.4%
  • Circular RNAs in diseases2.2%
  • Thyroid Disorders and Treatments1.7%
  • Other80.7%

Coauthors

All papers

Open in search
  1. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

    Authors: , , , , , , , , , , , , , , , , , - Thyroid 2015 cited by 2,400

  2. ROS homeostasis and metabolism: a dangerous liason in cancer cells

    Authors: , - Cell Death and Disease 2016 cited by 1,146

  3. miR-126 Regulates Angiogenic Signaling and Vascular Integrity

    Authors: , , , , , , , , , - Developmental Cell 2008 cited by 1,701

  4. Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 1,550

  5. NCOA4 Deficiency Impairs Systemic Iron Homeostasis

    Authors: , , , , , , , , - Cell Reports 2016 cited by 240

  6. Blood flow controls bone vascular function and osteogenesis

    Authors: , , , , , , , , , , , - Nature Communications 2016 cited by 415

  7. The Antioxidant Role of Non-mitochondrial CoQ10: Mystery Solved!

    Authors: - Cell Metabolism 2020 cited by 114

  8. The importance of the RET gene in thyroid cancer and therapeutic implications

    Authors: , , - Nature Reviews Endocrinology 2021 cited by 175

  9. A mitochondrial contribution to anti-inflammatory shear stress signaling in vascular endothelial cells

    Authors: , , , , , , , , , , , , , , - The Journal of Cell Biology 2022 cited by 86

  10. Long Covid: where we stand and challenges ahead

    Authors: , , , , , , , , , , , , , , , - Cell Death and Differentiation 2022 cited by 120

  11. BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

    Authors: , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2003 cited by 1,054

  12. UBIAD1 and CoQ10 protect melanoma cells from lipid peroxidation-mediated cell death

    Authors: , , , , , , , - Redox Biology 2022 cited by 30

  13. Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathway

    Authors: , , , , , , , , , - Oncogene 2015 cited by 211

  14. Adaptive redox homeostasis in cutaneous melanoma

    Authors: , - Redox Biology 2020 cited by 74

  15. NCOA4 links iron bioavailability to DNA metabolism

    Authors: , , , , , , - Cell Reports 2022 cited by 51

  16. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

    Authors: , , , , , , , , , - Cell 1990 cited by 967

  17. Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update

    Authors: , , , - The Journal of Clinical Endocrinology & Metabolism 2013 cited by 334

  18. RET Gene Fusions in Malignancies of the Thyroid and Other Tissues

    Authors: , , , - Genes 2020 cited by 134

  19. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer

    Authors: , , , , , , , , , , , - Nature Medicine 2002 cited by 703

  20. Cellular and molecular facets of keratinocyte reepithelization during wound healing

    Authors: , - Experimental Cell Research 2004 cited by 401

  21. ZebraBeat: a flexible platform for the analysis of the cardiac rate in zebrafish embryos

    Authors: , , , , , , - Scientific Reports 2014 cited by 175

  22. ROS signaling and redox biology in endothelial cells

    Authors: , - Cellular and Molecular Life Sciences 2015 cited by 165

  23. Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application

    Authors: , , , , , , , , - Journal of Medicinal Chemistry 2018 cited by 87

  24. The circadian protein BMAL1 supports endothelial cell cycle during angiogenesis

    Authors: , , , , - Cardiovascular Research 2023 cited by 39